Andrew G. Franks

7.6k total citations
99 papers, 1.2k citations indexed

About

Andrew G. Franks is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Andrew G. Franks has authored 99 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 32 papers in Dermatology and 31 papers in Rheumatology. Recurrent topics in Andrew G. Franks's work include Systemic Lupus Erythematosus Research (18 papers), Systemic Sclerosis and Related Diseases (18 papers) and Autoimmune Bullous Skin Diseases (14 papers). Andrew G. Franks is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Systemic Sclerosis and Related Diseases (18 papers) and Autoimmune Bullous Skin Diseases (14 papers). Andrew G. Franks collaborates with scholars based in United States, Australia and Sweden. Andrew G. Franks's co-authors include Joseph F. Merola, Miguel Sanchez, Victoria P. Werth, Richard L. Bakst, Robin Ashinoff, Kristen Lo Sicco, Hideko Kamino, Nicholas A. Soter, Siamak Moghadam‐Kia and Ali Jabbari and has published in prestigious journals such as The Lancet, American Journal Of Pathology and PLoS Medicine.

In The Last Decade

Andrew G. Franks

94 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew G. Franks United States 20 431 430 378 330 242 99 1.2k
K. Tamaki Japan 16 267 0.6× 539 1.3× 364 1.0× 255 0.8× 234 1.0× 59 1.5k
Aikaterini Patsatsi Greece 23 547 1.3× 364 0.8× 676 1.8× 452 1.4× 409 1.7× 126 1.6k
Edit Gyimesi Hungary 21 308 0.7× 283 0.7× 168 0.4× 424 1.3× 111 0.5× 40 1.1k
Anikó Kapitány Hungary 22 101 0.2× 402 0.9× 297 0.8× 234 0.7× 328 1.4× 41 1.2k
Daniele Torchia Italy 17 252 0.6× 338 0.8× 381 1.0× 227 0.7× 206 0.9× 72 1.0k
Rosemarie Watson Ireland 16 127 0.3× 471 1.1× 319 0.8× 286 0.9× 66 0.3× 27 1.1k
Ümit Türsen Türkiye 22 188 0.4× 464 1.1× 509 1.3× 329 1.0× 282 1.2× 112 2.1k
Pravin Hissaria Australia 20 335 0.8× 305 0.7× 153 0.4× 379 1.1× 209 0.9× 92 1.6k
B Kalis France 19 393 0.9× 147 0.3× 420 1.1× 295 0.9× 207 0.9× 81 1.2k
Paolo Romanelli United States 22 421 1.0× 475 1.1× 861 2.3× 510 1.5× 458 1.9× 112 2.0k

Countries citing papers authored by Andrew G. Franks

Since Specialization
Citations

This map shows the geographic impact of Andrew G. Franks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Franks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Franks more than expected).

Fields of papers citing papers by Andrew G. Franks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew G. Franks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Franks. The network helps show where Andrew G. Franks may publish in the future.

Co-authorship network of co-authors of Andrew G. Franks

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew G. Franks. A scholar is included among the top collaborators of Andrew G. Franks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew G. Franks. Andrew G. Franks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Curtiss, Paul H., et al.. (2022). Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon. Journal of the American Academy of Dermatology. 90(2). 223–234. 8 indexed citations
3.
Milam, Emily C., Kathryn J. Martires, Kristen I. Lo Sicco, David J. Araten, & Andrew G. Franks. (2019). A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation. JAAD Case Reports. 5(3). 228–230. 1 indexed citations
4.
Franks, Andrew G., et al.. (2019). Case report of discoid lupus erythematosus in association with electronic cigarette use. JAAD Case Reports. 5(12). 1030–1032. 6 indexed citations
5.
Sicco, Kristen I. Lo, et al.. (2017). Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum. JAAD Case Reports. 3(3). 228–229. 25 indexed citations
6.
Ramachandran, Sarika, et al.. (2017). Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands. Lupus Science & Medicine. 4(1). e000207–e000207. 5 indexed citations
7.
Wiznia, Lauren E., et al.. (2017). Hepatitis C virus and its cutaneous manifestations: treatment in the direct‐acting antiviral era. Journal of the European Academy of Dermatology and Venereology. 31(8). 1260–1270. 14 indexed citations
8.
Feig, Jessica L., Keith M. Giles, Iman Osman, & Andrew G. Franks. (2015). How MicroRNAs Modify Protein Production. Journal of Investigative Dermatology. 135(5). 1–5. 6 indexed citations
9.
Martires, Kathryn J., et al.. (2015). Sarcoidosis. Dermatology Online Journal. 21(12). 2 indexed citations
10.
Boyd, Kevin P., et al.. (2013). Necrolytic acral erythema. Dermatology Online Journal. 19(12). 15–15. 10 indexed citations
11.
Fernández, Patricia, Miguel Pérez‐Aso, Gideon P. Smith, et al.. (2013). Extracellular Generation of Adenosine by the Ectonucleotidases CD39 and CD73 Promotes Dermal Fibrosis. American Journal Of Pathology. 183(6). 1740–1746. 43 indexed citations
12.
Jabbari, Ali, Mayte Suárez‐Fariñas, Judilyn Fuentes‐Duculan, et al.. (2013). Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis. Journal of Investigative Dermatology. 134(1). 87–95. 86 indexed citations
13.
Buyon, Jill P., Andrew G. Franks, Richard Furie, et al.. (2013). THU0271 Favorable Clinical Response to Belimumab at Three Months. Annals of the Rheumatic Diseases. 72. A257–A257. 2 indexed citations
14.
Hunt, Raegan, et al.. (2012). Ulcerative sarcoidosis - eScholarship. Dermatology Online Journal. 18(12). 2 indexed citations
15.
Meehan, S., et al.. (2009). Mixed immunobullous disorder most consistent with the IgA-form of epidermolysis bullosa acquisita. Dermatology Online Journal. 15(8). 19–19. 2 indexed citations
16.
Franks, Andrew G.. (2009). Skin Manifestations of Internal Disease. Medical Clinics of North America. 93(6). 1265–1282. 37 indexed citations
17.
Bakst, Richard L., Joseph F. Merola, Andrew G. Franks, & Miguel Sanchez. (2008). Raynaud's phenomenon: Pathogenesis and management. Journal of the American Academy of Dermatology. 59(4). 633–653. 116 indexed citations
18.
Brancaccio, Ronald R., et al.. (1998). Six-Hour Versus 48-Hour Patch Testing With Varying Concentrations of Potassium Dichromate. Dermatitis. 9(2). 92–95. 3 indexed citations
19.
Jacobson, Mark, et al.. (1989). Desquamative inflammatory vaginitis. A case report.. PubMed. 34(9). 647–50. 9 indexed citations
20.
Franks, Andrew G., et al.. (1969). Gustatory sweating associated with unilateral hyperpigmentation.. PubMed. 99(6). 734–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026